RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
76 hedge funds and large institutions have $771M invested in Rubius Therapeutics, Inc in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 22 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 11
100% less call options, than puts
Call options by funds: $3K | Put options by funds: $950K
Holders
76
Holding in Top 10
4
Calls
$3K
Puts
$950K
Top Buyers
| 1 | +$20.1M | |
| 2 | +$12.8M | |
| 3 | +$5.35M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$2.52M |
| 5 |
Millennium Management
New York
|
+$1.76M |
Top Sellers
| 1 | -$26.3M | |
| 2 | -$3.86M | |
| 3 | -$3.41M | |
| 4 |
Alkeon Capital Management
New York
|
-$3.14M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$699K |